Uncommon Information

View Top Employees from Uncommon

Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine.

Website	http://www.uncommonbio.co
Employees	8 (5 on RocketReach)
Founded	2017
Address	Newmarket Road, Cambridge, England CB5 8PB, GB
Industry	Biotechnology Research
Keywords	Cultivated Meat, Cultured Meat, Cell-Based Meat, Lab-Grown Meat, Alternative Protein, Clean Meat, Cellular Agriculture, Sustainable Protein, Food Technology, Protein Innovation, In Vitro Meat, Animal-Free Meat, Plant-Based Meat Alternative, Biotechnology, Meat Production, Food Science, Novel Protein, Healthy Meat
Competitors	Sustainable Bioproducts, Zymergen, Inc., Bolt Threads, Amgen, LanzaTech, Twist Bioscience, Geno, C16 Biosciences, Carbon Clean, Solugen +30 more (view full list)